 |
||||||||||||||||||||||
|
Partners
Bio-Outsourcing Asia© provides a comprehensive view of outsourcing issues facing the biopharmaceutical and biomedical industries as partnerships are formed with established and emerging Asian markets. Read about opportunities in India, China, Malaysia, Singapore, Taiwan and more. www.canbiotech.com/CBBOA.asp
HPV Today is a quarterly international newsletter reporting advances on HPV research with focus on the implications for the prevention of disease and clinical management of patients. HPV Today aims at disseminating information and educated opinion on the growing spectrum of conditions linked to HPV infections. A central goal of the newsletter is to contribute to the acceleration of the programs of cervical cancer prevention in the world.
We know you're busy. That's why we compile the latest cell therapy research, policy and business news, and deliver it to your inbox in one weekly e-newsletter. Join more than 11,000 of your colleagues - scientists and business professionals in the cell therapy industry – who receive Cell Therapy News each week. Subscribe at www.celltherapynews.com/subscribe.
The vaccine field has been transformed by the technological advances of the past decade. We are now beginning to visualize the future impact of vaccines, in terms of both healthcare and economics. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies. It provides the key information needed by decision makers in the development and application of vaccines – from concept to clinic.
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
The Scientist, the award-winning magazine of the life sciences, provides compelling print and online coverage of the latest developments in the life sciences including research, technology, and business. We entertain and inform our readers, keeping them up-to-date with research advances, events, culture, technical innovations and career advice.
The BioProcessing Journal is a peer-reviewed, quarterly publication that features the latest technological advancements and best practices for the development and production of safe and effective biologics. Since 2002, the journal has been a leading source of industry trends and techniques for process efficiency with its content specifically designed for professionals in process and analytical methods development, manufacturing, quality systems, regulatory affairs, facility design, and contract services.
The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. The valuable role of immunotherapy in oncology is increasingly recognized alongside conventional chemo- and radio-therapies, and the US Food and Drug Administration has approved the use of immunotherapy in melanoma, leukemias, lymphomas and myelomas, and in breast, cervical, ovarian, kidney, prostate and colorectal cancers. Immunotherapeutics are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV/AIDS and hepatitis.
DNAvaccine.com is dedicated to giving the professional in the DNA Vaccine community access to the latest information in their field. In addition, we seek to establish a network of connections among these professionals for the purpose of maintaining a free flow of information"
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com
Pharmalicensing is used by over 90,000 users per month and is a division of UTEK Corporation. Visit www.pharmalicensing.com
Human Vaccines is a unique new peer-reviewed journal with an international audience that covers the following topics: discovery, research, enabling technologies, preclinical development, toxicology, product development, assays and quality control, process development, clinical studies, regulatory affairs, commercial, utilization, policy, safety, epidemiology, preventive vaccines, therapeutic vaccines, infectious disease targets, and non-infectious disease targets, e.g., cancer, allergy, autoimmunity. Online submission and peer review. Indexed by Medline/PubMed.
mAbs is a new peer-reviewd journal launched in 2009 and published by Landes Bioscience. It is the first international peer-reviewed journal to provide a forum for communication on the topic of monoclonal antibody research and development, with a focus on therapeutics.
©Copyright Phacilitate Limited 2010
|
|
||||||||||||||||||||
